Tag | Content |
---|
EnhancerAtlas ID | HS100-00215 |
Organism | Homo sapiens |
Tissue/cell | HT1080 |
Coordinate | chr22:20862990-20864500 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
CEBPA | MA0102.3 | chr22:20864015-20864026 | ATTGCACAATC | + | 6.32 | EWSR1-FLI1 | MA0149.1 | chr22:20863896-20863914 | GGAAGGAAGGAAGCCGGG | + | 7.53 | RREB1 | MA0073.1 | chr22:20863863-20863883 | TGGAGGGGGGTGGGGTGTGG | - | 7.13 |
|
| Number of super-enhancer constituents: 27 | ID | Coordinate | Tissue/cell |
SE_00966 | chr22:20863023-20863979 | Adrenal_Gland | SE_00966 | chr22:20864176-20865215 | Adrenal_Gland | SE_02445 | chr22:20861486-20864484 | Astrocytes | SE_08018 | chr22:20860731-20865682 | Brain_Inferior_Temporal_Lobe | SE_13928 | chr22:20861194-20864740 | CD34_Primary_RO01536 | SE_14430 | chr22:20860672-20867030 | CD4_Memory_Primary_7pool | SE_18628 | chr22:20861082-20865667 | CD4p_CD25-_Il17-_PMAstim_Th | SE_20981 | chr22:20860783-20865474 | CD8_Memory_7pool | SE_22532 | chr22:20861281-20865753 | CD8_primiary | SE_27539 | chr22:20863024-20866302 | Esophagus | SE_34166 | chr22:20861654-20866180 | HCC1954 | SE_36027 | chr22:20861482-20865684 | HMEC | SE_36960 | chr22:20860758-20866173 | HSMMtube | SE_40040 | chr22:20860761-20864480 | K562 | SE_41024 | chr22:20861109-20865393 | Left_Ventricle | SE_44170 | chr22:20861161-20865473 | NHDF-Ad | SE_45006 | chr22:20861483-20864534 | NHLF | SE_45715 | chr22:20861183-20866292 | Osteoblasts | SE_48978 | chr22:20863016-20864502 | Right_Atrium | SE_51756 | chr22:20861398-20864353 | Skeletal_Muscle_Myoblast | SE_53780 | chr22:20862985-20865250 | Spleen | SE_56041 | chr22:20861179-20864469 | u87 | SE_57293 | chr22:20863043-20864302 | VACO_400 | SE_63544 | chr22:20861322-20864485 | HSMM | SE_64517 | chr22:20861496-20865482 | NHEK | SE_65524 | chr22:20861097-20864100 | Pancreatic_islets | SE_67959 | chr22:20861179-20864469 | u87 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | AATGGTGGAA TGTCATCAGT TACGGCTGTT TTTACTTCTT TTGTGGATCT TCAGTTACTT 60 CAGGCCATCT GGATGTATAC GTGCAAGTCA CAGGGGATGC GATGGCCTGG CCTGGGCTCA 120 GAGGCCTGAC AGTTTTTAAC TGAGCTTATT GGCGTGTTGT GCTCGCCACA GATTTGCCTG 180 AGACACAGCC CCTTTCCTGA GGGATGGTAA AGGAACCGTC ACAGCGCAGT CTTGTCAGTC 240 TGTAATGTGT ATACTGCAGG GGTTTCTTGC GAAGCGGCGG TTAACTTGAG CAGACCAGGG 300 GCAGTCTAGT GAGTAGGTGA CGAATAAATT GAGTCCTAGA AAGACAAGTA GGAGTGTGAA 360 TAGCCACCAT TCCAAGCTGA GGAGTTAGGA AACATGAGCA TTTACTGCGT GGAGGGAGGA 420 TCTTGTAGGC TGAGAGTTCT GGGGCTCGAG GAGTAAGAGA GCCCAGGAGA TGATGGAATG 480 AGGGTGAGCA GGTACTAGCA CTTTAGTGGG GGTGTTGTGC CAAGGAATTG AGCCTGTGTT 540 TGGCATGTGG CATTCTTTGG AGTAGTGAAA TGCCAGTGTT GGGAATATGC CTAGAGTCCC 600 TGTCCCTGGA GATGGATGCA GGGCAGAGAA GAGAGACCAG TTAAGCTATT AAGAGAGTTT 660 GAACATTTGG AGGGAGTAGG GAACCTGTCC TTTTTCATCC TTATATTCTC ACTGCTAGCT 720 CACTGCCTGC CACATTGCTC CGTAAAATGA TTGTGGCATG ACCTAGTCGG GCGGGAGATT 780 ATAAAGGCCT GCATTAGACA GTGGTAGAAA CTGAAAGAGG AAGACAGATT CCAGAGGAGG 840 GGGAACGTAG ACAATTCTTG ATGACTAACT GGATGGAGGG GGGTGGGGTG TGGGGTGAAG 900 CATTGTGGAA GGAAGGAAGC CGGGCTGAAT GCTGGGAAAC CTTTCAGTAC AGTGGAAAGA 960 GTAGGGACTG TAGAGTTAGT AGCTATGGGC TTTGGGAAGA ATAGCCTTGG GATATTTCTG 1020 GGGATATTGC ACAATCAGTG AACAGTGTTT TACTGATAAA ATATAGTTAT CTGTAGGTGA 1080 AAACTTGAGA GATATCCCAC TTCAGGGTTC CTGCAAGAAA AGTCCCCAGG GCAAGGGTTC 1140 TTCTCTGGGA AAGCCCAGAA TTAAGAACTG GAAGGGTGAG TTGTCATCAA AGAAAATGGG 1200 GGTAGGGGAA GTGTTAAGAG GGCTGGGAGG GTGATTGAAG AGTTTATGGG TGTTGAGTGA 1260 CTGGATACTT CATAACTCAG CTTTATTTTG CTTCCGGGAG AATTGAGTTC TTTATTTTTT 1320 TCGATATTGC TGTTTGTGTG TTTTTCTGTT GCCGCTCTAA CAAATTACCA CAAGTTTAGC 1380 ATCTTAAAAC AACACACCTT TAGCCAGGTG TGGTGGCTCA CGCCTGTAAT CCCAGCACTT 1440 TGGGAGACTG AGGCAGGCGG ATCACGAGGT CAAGAGACTG AGACCCATCC TGGCCAACAC 1500 GGTGAAACCC 1510
|